Altho ugh p las m a n itr ite is a s table e nd p ro duct of NO o x idation de rived fr om en do ge n ous NO, th e p las m a n itr ite lev el is also eas ily affe cted by th e in take o f v arious foods , ba cteria l p r oducts an d r e nal function al s tatus . Aims : We p ro p os e an e x cellen t alte r native as s ay tech n iqu e for m eas urin g en do ge n ous NO pr o duction .
Introduction
Various factors are involved in the pathogenesis of septic shock. Among them, recent interest has been centred on the nitric oxide (NO) pathway. 1 Evidence for its involvement stems from the observation that a specific NO synthase inhibitor prevented endotoxininduced hypotension in an experimental model 2 and that in patients with septic shock resistant to the treatment with a certain NOS inhibitor and to an increase in blood pressure. 3 In order to determine the influence of sepsis on the endogenous NO production in humans, plasma nitrite levels were conventionally measured, because nitrite is a very stable oxidation product. However, a drawback of this method is that plasma nitrite is derived from not only endogenous NO, but also from various foods and bacterial products. In addition, nitrite levels are easily affected by the renal functional status. 4 Therefore, we consider, it is almost impossible to measure endogenously produced NO alone in the blood. We tried to measure the endogenous NO producing activity of patients with sepsis by means of cultured vascular smooth muscle cells (SMC). Sera from patients with sepsis induced NO production in the SMC, but those from control subjects did not.
These data suggest that our assay system can be useful for the evaluation of the endogenous NO producing activity in pathological conditions such as sepsis.
Patients and methods

Patient
Four patients (1 male and 3 female), aged 47-68 years, who were diagnosed as having sepsis were recruited in the study. Patients were judged clinically to have septicaemia if they had a high fever (>38.5°C) and tachycardia (>110/min). All the patients had the haematological malignancies (1 case of acute lymphoblastic leukemia, 1 of myelodysplastic syndrome and 2 of chronic myeloblastic leukemia), as shown in Table 1 . Blood samples were obtained within 24 hours of the diagnosis of septicaemia. Serum was separated immediately by centrifugation, frozen, and kept at -80°C until analysis.
here, the cells were inoculated into wells (16 mm, 200 mm 2 ) (Iwaki Glass, Tokyo) containing MEM supplemented with 10% FCS and maintained at 37°C in an incubator under a humidified atmosphere of 95% air and 5% CO 2 .
NO measurement
Confluent SMCs were washed twice with MEM and treated with MEM containing 10% serum obtained from a patient with sepsis. After 24 hours, the amount of NO released from the SMC was measured as nitrite in this medium and in aqueous solution by means of a chemiluminescence detector (Silvers Instruments, Inc., CO). 6, 7 Nitrite concentration was determined using sodium nitrite (NaNO 2 , Wako, Osaka) as the standard. The background signal in the medium was subtracted from each measured value. The NO production was calculated as follows; NO production = test value -blank value Blank means the nitrite from MEM supplemented with serum.
Lipopolysacharide (LPS; Sigma Co Ltd, MO) induced nitrite production from SMC for 24 hours (0.5 ng/ml of LPS: 27.0±4.3 pmol/well, 1 ng/ml of LPS: 40.2±6.9 pmol/well).
Results
Sera from patients with sepsis induced NO production from SMC. In Table 1 , clinical data on 4 patients with sepsis are shown. None of the patients had hypotension. Three cases showed neutropenia (<500/ml). The samples from all these patients significantly induced nitrite production in cultured SMC (5.95±1.5 pmol/well, p<0.05 vs. normal subjects; 0.50±0.02 pmol/well). On the other hand, serum obtained from the same patients after the treatment from sepsis did not induce nitrite production in the SMC (0.86±0.2 pmol/well), as shown in Fig. 1(A) . Furthermore, sera obtained from normal subjects (N=4) also did not increase the nitrite production in the SMC (0.38±0.08 pmol/well). Table 1 . The data represent the means ±SEM of 8 wells. Each experiment was repeated 3 times.
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Effect of a specific NOS inhibitor on the NO production induced by the septic sera L-nitroarginine (1 mmol/L), a specific NOS inhibitor, was concomitantly added to the cultured SMC treated with MEM containing 10% sera obtained from the patients with sepsis (cases 1 and 4). L-nitroarginine suppressed the increase in nitrite level as shown in Fig. 1(B) . On the other hand, D-nitroarginine, an optical isomer, which does not inhibit NOS activity, did not affect the increase in nitrite level.
Discussion
L-nitroarginine, but not D-nitroarginine, inhibited the production of nitrite in cultured SMC induced by sera obtained from patients with sepsis, suggesting that the nitrite was derived from iNOS in the SMC. Using the proposed assay technique, the activity of endogenous NO production can be evaluated. Even sera obtained from patients with sepsis who did not have hypotension induced an increase in the nitrite production in the SMC. We measured the nitrite levels in the medium of cultured SMC treated with serum obtained from two patients with septic shock (15.2 and 17.5 pmol/well, respectively). Despite evaluation of only two cases, this assay technique is considered beneficial for the severity of sepsis. It has been previously reported that the plasma nitrite levels increased in patients with sepsis. 8 However, plasma nitrite is derived from not only endogenous NO, but also from various foods and bacterial products. In sepsis, bacteria induce the release of massive amounts of nitrite in the blood. We consider that the plasma nitrite level does not directly reflect the endogenous NO production.
Our assay method measures only the ability for the endogenous NO production of an individual person. However, there are also some disadvantages of this technique. 1 The substances that induce NO production are unclear. We consider that various interleukins, such as interleukin 1 and 6, and so on in the serum may induce iNOS in SMC. 2 Even in the case of septic shock, the endogenous NO production in SMC is low (pmol/well). Thus, it is possible that SMC are not adequate as target cells. On the other hand, since the NO production in macrophage cell lines is massive, in further experiments, we propose to measure the nitrite levels using macrophage cell lines. Moreover, because only four patients with sepsis were evaluated in this study, we propose to enrol many patients with sepsis and septic shock to evaluate the endogenous NO producing activity in the patients.
